Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

The VEGF Receptor Tyrosine Kinase Inhibitor Pazopanib in Combination with the MEK Inhibitor Trametinib in Advanced Solid Tumors and Differentiated Thyroid Cancers.

Kurzrock R, Ball DW, Zahurak ML, Nelkin BD, Subbiah V, Ahmed S, O'Connor A, Karunsena E, Parkinson RM, Bishop JA, Ha Y, Sharma R, Gocke CD, Zinner R, Rudek MA, Sherman SI, Azad NS.

Clin Cancer Res. 2019 Jun 11. pii: clincanres.1881.2018. doi: 10.1158/1078-0432.CCR-18-1881. [Epub ahead of print]

PMID:
31186313
2.

The assimilation of Western medicine into a semi-nomadic healthcare system: a case study of the Indigenous Aeta Magbukún, Philippines.

Balilla VS, McHenry JA, McHenry MP, Parkinson RM, Banal DT.

Ecohealth. 2014 Sep;11(3):372-82. doi: 10.1007/s10393-014-0919-x. Epub 2014 Mar 19.

PMID:
24643860
3.

Egr3 induces a Th17 response by promoting the development of γδ T cells.

Parkinson RM, Collins SL, Horton MR, Powell JD.

PLoS One. 2014 Jan 24;9(1):e87265. doi: 10.1371/journal.pone.0087265. eCollection 2014.

4.

Plasmids encoding the mucosal chemokines CCL27 and CCL28 are effective adjuvants in eliciting antigen-specific immunity in vivo.

Kutzler MA, Kraynyak KA, Nagle SJ, Parkinson RM, Zharikova D, Chattergoon M, Maguire H, Muthumani K, Ugen K, Weiner DB.

Gene Ther. 2010 Jan;17(1):72-82. doi: 10.1038/gt.2009.112. Epub 2009 Oct 22.

PMID:
19847203
5.

The interpretation of ELISA results by means of the standard deviation ratio.

Parkinson RM, Conradie JD, Milner LV, Marimuthu T.

J Immunol Methods. 1988 Nov 25;115(1):105-10.

PMID:
3192940

Supplemental Content

Loading ...
Support Center